CL on NYSE

Colgate-Palmolive Company

Logo: Colgate-Palmolive, Public domain, via Wikimedia Commons6

American multinational consumer products company

The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products.3 It was founded by William Colgate.1 Its chief executive is Noel Wallace (since 2019).1 Its revenue was $18 billion in 2022.1 Its shares trade on NYSE under the symbol CL.1 Wikipedia text CC BY-SA 4.0

$93.26 down 1.28 (1.35%)Price as of Oct 21, 2026 at 18:59 UTC

Last updated Oct 21, 2026.

Overview

1806Founded1

Compare with Kenvue, Estée Lauder Companies or Coty, or pick any stock.

  • TickerCL on NYSE1
  • Industrypersonal care product1
  • HeadquartersNew York City1
  • Websitewww.colgatepalmolive.com
  • Legal formDelaware corporation1
  • Incorporated inDE7
  • Business address300 Park Ave, New York, Ny 100227
  • Filer categoryLarge accelerated filer7
  • LEIYMEGZFW4SBUSS5BQXF884
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressCORPORATION TRUST CENTER 1209 ORANGE ST, 19801 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 1563134
Colgate-Palmolive Building 300 Park Avenue
Photo: Beyond My Ken, CC BY-SA 4.0, via Wikimedia Commons10

The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

60.1%Gross margin11
16.2%Operating margin11
10.5%Net margin11
1.4%Revenue growth, 202511
3948.1%Return on equity11
127.24×Debt to equity11

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Oral, Personal and Home Care brought in 77% of the revenue Colgate-Palmolive Company broke down this way in fiscal 2025.

  1. Oral, Personal and Home Care$15.8B1177%up 1% from 2024
  2. Pet Nutrition$4.6B1123%up 3% from 2024
Business segments by year
Business segments202320242025
Oral, Personal and Home Care$15.2B$15.6B$15.8B
Pet Nutrition$4.3B$4.5B$4.6B

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue40¢$8.1B
  • Research and development2¢$366.0M
  • Selling, general and admin39¢$7.9B
  • Other costs5¢$1.1B
  • Income tax4¢$798.0M
  • Profit10¢$2.1B

Out of $20.4B in revenue.11

Where each dollar of operating cash went, fiscal 2025

  • Share buybacks29¢$1.2B
  • Kept or used elsewhere71¢$3.0B

Out of $4.2B of cash from operations.11

Financial statements

Revenue1213141511$20.4B in 2025+30% since 2019
0$10.0B$20.0B$30.0B2019: $15.7B$15.7B20192020: $16.5B$16.5B2020+5%2021: $17.4B$17.4B2021+6%2022: $18.0B$18.0B2022+3%2023: $19.5B$19.5B2023+8%2024: $20.1B$20.1B2024+3%2025: $20.4B$20.4B2025+1%
Gross profit1213141511$12.3B in 2025+31% since 2019
0$5.0B$10.0B$15.0B2019: $9.3B$9.3B20192020: $10.0B$10.0B2020+7%2021: $10.4B$10.4B2021+4%2022: $10.2B$10.2B2022−1%2023: $11.3B$11.3B2023+11%2024: $12.2B$12.2B2024+7%2025: $12.3B$12.3B2025+1%
Operating income1213141511$3.3B in 2025−7% since 2019
0$2.0B$4.0B$6.0B2019: $3.6B$3.6B20192020: $3.9B$3.9B2020+9%2021: $3.3B$3.3B2021−14%2022: $2.9B$2.9B2022−13%2023: $4.0B$4.0B2023+38%2024: $4.3B$4.3B2024+7%2025: $3.3B$3.3B2025−23%
Net income1213141511$2.1B in 2025−10% since 2019
0$1.0B$2.0B$3.0B2019: $2.4B$2.4B20192020: $2.7B$2.7B2020+14%2021: $2.2B$2.2B2021−20%2022: $1.8B$1.8B2022−18%2023: $2.3B$2.3B2023+29%2024: $2.9B$2.9B2024+26%2025: $2.1B$2.1B2025−26%

Every line of the income statement as filed: the last 3 fiscal years, latest first.11

Period ending2025-12-312024-12-312023-12-31
Net sales$20.4B$20.1B$19.5B
Cost of sales$8.1B$7.9B$8.1B
Gross profit$12.3B$12.2B$11.3B
Selling, general and administrative expenses$7.9B$7.7B$7.2B
Other (income) expense, net$123.0M$164.0M$191.0M
Goodwill and intangible assets impairment charges$919.0M$0$0
Operating profit$3.3B$4.3B$4.0B
Non-service related postretirement costs$55.0M$87.0M$360.0M
Interest expense$267.0M$292.0M$287.0M
Interest income$75.0M$67.0M$55.0M
Income before income taxes$3.1B$4.0B$3.4B
Global effective tax rate$798.0M$907.0M$937.0M
Net income including noncontrolling interests$2.3B$3.0B$2.5B
Less: Net income attributable to noncontrolling interests$129.0M$160.0M$155.0M
Net income attributable to Colgate-Palmolive Company$2.1B$2.9B$2.3B
Earnings per common share, basic (in dollars per share)$2.64$3.53$2.78
Earnings per common share, diluted (in dollars per share)$2.63$3.51$2.77

Compare Colgate-Palmolive Company with another company

Corporate structure

Colgate-Palmolive Company sits at the top of its group. 231 entities, 74 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Colgate-Palmolive Company

  • VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on Colgate-Palmolive Company, latest Apr 29, 2026
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on Colgate-Palmolive Company, latest Mar 26, 2026 (5 filings since Feb 9, 2022)
  • BlackRock Filed SC 13G/A on Colgate-Palmolive Company, latest Nov 12, 2024 (5 filings since Feb 1, 2022)
  • State Street Corporation Filed SC 13G/A on Colgate-Palmolive Company, latest Jan 25, 2024 (3 filings since Feb 14, 2022)
  • Colgate-Palmolive Company New York, New York, United States
    • Colgate-Palmolive (Switzerland) Subsidiary · Therwil, Switzerland
    • Elmex Subsidiary
    • Sanex Subsidiary
    • Science Diet Subsidiary · Topeka
    • บริษัท คอลเกต-ปาล์มโอลีฟ (ประเทศไทย) จำกัด Subsidiary · 100% · กรุงเทพมหานคร, Thailand
    • Care BidCo Pty Ltd Subsidiary · Australia
    • Care MezzCo Pty Ltd Subsidiary · Australia
    • Care MidCo Pty Ltd Subsidiary · Australia
    • Care TopCo Pty Ltd Subsidiary · Australia
    • Cleaning Dimensions, Inc. Subsidiary · Delaware, United States
    • Clever Pet (Vic) Pty Ltd Subsidiary · Australia
    • Colgate (BVI) Limited Subsidiary · British Virgin Islands
    • Colgate (Guangzhou) Company Limited Subsidiary · China
    • Colgate Business Services of the Americas, S.C. Subsidiary · Mexico
    • Colgate Flavors and Fragrances, Inc. Subsidiary · Delaware, United States
    • COLGATE GLOBAL BUSINESS SERVICES PRIVATE LIMITED Subsidiary · Mumbai, India
    • Colgate Holdings Subsidiary · United Kingdom
    • Colgate Oral Pharmaceuticals, Inc. Subsidiary · Delaware, United States
    • Colgate Palmolive Ghana Limited Subsidiary · Ghana
    • Colgate Palmolive Holding S.Com.P.A. Subsidiary · Spain
    • Colgate Palmolive Tanzania Limited Subsidiary · Tanzania
    • Colgate Sanxiao Company Limited Subsidiary · China
    • Colgate Tolaram Pte. Ltd. Subsidiary · Singapore
    • Colgate Venture Company, Inc. Subsidiary · Delaware, United States
    • Colgate, Inc. Subsidiary · Delaware, United States
    • and 212 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Colgate-Palmolive Company reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Land$234.0M11 Dec 31, 2025$226.0M11 Dec 31, 2024+3.5%
Buildings and improvements$2.2B11 Dec 31, 2025$2.1B11 Dec 31, 2024+5.6%
Machinery and equipment$6.9B11 Dec 31, 2025$6.3B11 Dec 31, 2024+10.7%
Property and equipment, before depreciation$10.9B11 Dec 31, 2025$10.1B11 Dec 31, 2024+7.2%
Accumulated depreciation$6.2B11 Dec 31, 2025$5.7B11 Dec 31, 2024+8.6%
Property and equipment, net$4.7B11 Dec 31, 2025$4.4B11 Dec 31, 2024+5.4%
Operating-lease assets (leased space)$531.0M11 Dec 31, 2025$529.0M11 Dec 31, 2024+0.4%

Real estate and locations

ItemLatestA year beforeChange
Countries it operates in20011 Dec 31, 202520015 Dec 31, 20240%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$1.3B11 Dec 31, 2025$1.1B11 Dec 31, 2024+17.5%
Marketable securities, current$107.0M11 Dec 31, 2025$160.0M11 Dec 31, 2024−33.1%
Stakes in other companies (equity method)$82.0M11 Dec 31, 2025$81.0M11 Dec 31, 2024+1.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$3.1B11 Dec 31, 2025$3.3B11 Dec 31, 2024−4.6%
Intangible assets, net (excluding goodwill)$1.5B11 Dec 31, 2025$1.8B11 Dec 31, 2024−12.5%
Accumulated amortization$1.0B11 Dec 31, 2025$930.0M11 Dec 31, 2024+11.7%

Inventory

ItemLatestA year beforeChange
Inventory, total$2.0B11 Dec 31, 2025$2.0B11 Dec 31, 2024+2.3%
Work in process$46.0M11 Dec 31, 2025$46.0M11 Dec 31, 20240%
Finished goods$1.5B11 Dec 31, 2025$1.4B11 Dec 31, 2024+3.4%

Properties, in its own words

We own or lease approximately 325 properties, which include manufacturing, distribution, research and development and office facilities worldwide. Our corporate headquarters is located in a leased property at 300 Park Avenue, New York, New York.

In the United States, we operate in approximately 85 properties, of which 17 are owned. Major U.S. manufacturing and warehousing facilities used by the Oral, Personal and Home Care product segment of our business are located in Ohio, South Carolina and Tennessee. The Pet Nutrition segment has major manufacturing and warehousing facilities in Indiana, Kansas, Kentucky, Ohio and Oklahoma.

The rest of Item 2

Outside the United States, we operate in approximately 240 properties, of which 59 are owned, in over 80 countries. Major overseas manufacturing and warehousing facilities used by the Oral, Personal and Home Care product segment of our business are located in Australia, Brazil, China, Colombia, France, Greece, Guatemala, India, Italy, Mexico, Poland, South Africa, Thailand, Türkiye and Vietnam. The Pet Nutrition segment has major manufacturing and warehousing facilities in Australia, Czech Republic, Italy and the Netherlands.

The primary research and development center for Oral Care and Personal Care products is located in New Jersey, the primary research and development center for Home Care products is located in Mexico and the primary research and development center for Pet Nutrition products is located in Kansas. Our global data center is also located in New Jersey.

We have shared business service centers in India, Mexico and Poland, which are located in leased properties.

All of the facilities we operate are well maintained and adequate for the purpose for which they are intended.

Item 2 of the 10-K filed Feb 23, 2026.22

Stakes and holdings (Wikidata)

Things Wikidata records the company as owning, with the share when stated.1

The story

Founded by William Colgate in 1806.1

William Colgate, an English immigrant to the United States and devout Baptist, established a starch, soap, and candle factory on Dutch Street in New York City under the name William Colgate & Company in 1806.

In 1833, he suffered a severe heart attack, stopping his business's sales; after a convalescence he continued with his business. In the 1840s, the company began selling individual cakes of soap in uniform weights. In 1857, Colgate died and the company was reorganized as Colgate & Company under the management of his similarly devout Baptist son Samuel Colgate, who did not want to continue the business but thought it would be the right thing to do. In 1872, he introduced Cashmere Bouquet, a perfumed soap.

In 1873, the company introduced its first Colgate toothpaste, an aromatic toothpaste sold in jars. In 1896, the company sold the first toothpaste in a tube, named Colgate Ribbon Dental Cream (invented by dentist Washington Sheffield). Also in 1896, Colgate hired Martin Ittner and under his direction founded one of the first applied research labs. By 1908, it initiated mass sales of toothpaste in tubes. Another of William Colgate's sons, James Boorman Colgate, was a primary trustee of Colgate University (formerly Madison University).

In Milwaukee, Wisconsin, the B. J. Johnson Company was making a soap from palm oil and olive oil, the formula of which had been developed by Burdett J. Johnson in 1898. The soap was so popular that the company was re-named Palmolive in 1917. Around the start of the 20th century, Palmolive was the world's best-selling soap.

In June 1928, rumors started that "officials of the Palmolive-Peet Co. are negotiating to purchase the Colgate Co.", privately held by the Colgate family. Peet Brothers Soap Company of Kansas City had merged with Palmolive two years before the merger with Colgate. The merger combined the three oldest and largest soap and perfumery companies in the US and became effective on July 1, 1928. The combined company was named the "Colgate Palmolive Peet Company". The combined pre-merger sales in 1927 of the three companies exceeded $100,000,000 (equivalent to $1.875000000×109 in 2025). The newly combined company had seven US manufacturing facilities as well as factories in 14 foreign countries. In 1953, the companies became a joint venture, known as the Colgate-Palmolive Company.

From Wikipedia’s article on Colgate-Palmolive, shared under CC BY-SA 4.0.8

Leadership

Who has led Colgate-Palmolive Company, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (77)

Products and brands

  • Protex
  • Speed Stick
  • mouthwash
  • toothbrush
  • toothpaste

Listed on Wikidata.1

Brands

Colgate-Palmolive now markets a broadly diversified mix of products in the United States and other countries. Major product areas include household and personal care products, food products, health care and industrial supplies, and sports and leisure time equipment.

Discontinued products and former brands

Ajax Laundry Detergent (Ajax Cleanser still made by Colgate-Palmolive)

Ad (detergent)

Bambeanos

Read the full text

Brisk (fluoride toothpaste)

Burst (detergent)

Cue (fluoride toothpaste)

Cashmere Bouquet (soap)

Cherish (cinnamon flavored toothpaste)

Cold Power (detergent)* (known in Canada as Arctic Power, Australian and New Zealand rights sold to Henkel in May 2015)

Coleo (soap)

Colgate Tooth Powder** and Colgate Chlorophyll Tooth Powder

Colgate Toothpaste with Chlorophyll**

Dynamo laundry detergent (liquid detergent-no longer made by CP in the U.S.)

Fab Detergent (no longer made by CP in the U.S.)

Fab One Shot (detergent)

Florient (room deodorizer)

Halo Shampoo

Kolynos (toothpaste)**

Lustre-Creme Shampoo

Octagon (soap)

Palmolive Rapid Shave

Colgate's Peter Pan Beauty Bar with Chlorophyll

Soaky (bubble bath for kids)

Super Suds (detergent)

Swerl (liquid cleanser)

Vel (dishwashing detergent)

Notes:

* While detergent brands continue to be manufactured and sold by Colgate in some countries, in the United States they have been sold to another company, Phoenix Brands in 2005. Phoenix Brands filed for bankruptcy in May 2016 and the US rights have been assumed by Fab & Kind Company.

In May 2015, Colgate-Palmolive sold its Australian laundry detergents and pre-wash brands to Henkel for US$245 million (€220 million). Colgate-Palmolive has divested its laundry detergents business in Colombia, which was in turn acquired by Unilever and some Asian countries, which was acquired by Procter & Gamble.

** Still being made by Colgate-Palmolive internationally, but no longer available in the U.S.

Facilities

In the U.S., the company operates approximately 60 properties, of which 14 are owned. Major U.S. manufacturing and warehousing facilities used by the oral, personal and home care segment of Colgate-Palmolive were located in Morristown, New Jersey (previously the headquarters of the Mennen company prior to its 1992 buyout, and still HQ of the Mennen division) until 2014, when the plant shut down and moved operations to Hodges, South Carolina; Morristown, Tennessee; and Cambridge, Ohio. The pet nutrition segment has major facilities in Bowling Green, Kentucky; Emporia, Kansas; Topeka, Kansas; and Richmond, Indiana. The primary research center for oral, personal and home care products is located in Piscataway, New Jersey and the primary research center for pet nutrition products is located in Topeka, Kansas.

Overseas, the company operates approximately 280 properties of which 80 are owned in over 70 countries. Major overseas facilities used by the oral, personal and home care segment are located in Australia, Brazil, China, Colombia, France, Guatemala, India, Italy, Malaysia, Mexico, Pakistan, Poland, South Africa, Thailand, Venezuela, Vietnam and elsewhere throughout the world.

Colgate-Palmolive has closed or is in the process of phasing out production at certain facilities under a restructuring program initiated in 2004 and has built new state-of-the-art plants to produce toothpaste in the U.S., Mexico and Poland.

Colgate-Palmolive's chief manufacturing plant is located in Burlington Township, New Jersey, producing all of the fragrance and flavor oils for the company's facilities around the world.

From Wikipedia’s article on Colgate-Palmolive, shared under CC BY-SA 4.0.8

Subsidiaries and ownership

Subsidiaries

Also owns

Subsidiaries (Exhibit 21)

  • CP GABA GmbH Germany9
  • CP International Holding C.V. Netherlands9
  • CP Skin Health Group, Inc. Delaware9
  • Care BidCo Pty Ltd Australia9
  • Care MezzCo Pty Ltd Australia9
  • Care MidCo Pty Ltd Australia9
  • Care TopCo Pty Ltd Australia9
  • Cleaning Dimensions, Inc. Delaware9
  • Clever Pet (Vic) Pty Ltd Australia9
  • Colgate (BVI) Limited British Virgin Islands9
  • Colgate (Guangzhou) Company Limited China9
  • Colgate Business Services of the Americas, S.C. Mexico9
  • Colgate Flavors and Fragrances, Inc. Delaware9
  • Colgate Global Business Services Private Limited India9
  • Colgate Holdings United Kingdom9
  • Colgate Oral Pharmaceuticals, Inc. Delaware9
  • Colgate Palmolive Ghana Limited Ghana9
  • Colgate Palmolive Holding S.Com.P.A. Spain9
  • Colgate Palmolive LLC United Arab Emirates9
  • Colgate Palmolive Tanzania Limited Tanzania9
  • Colgate Sanxiao Company Limited China9
  • Colgate Tolaram Pte. Ltd. Singapore9
  • Colgate Venture Company, Inc. Delaware9
  • Colgate, Inc. Delaware9
All 233 listed subsidiaries
  • Colgate-Palmolive (America) Inc. Delaware9
  • Colgate-Palmolive (Asia) Pte. Ltd Singapore9
  • Colgate-Palmolive (Blantyre) Limited Malawi9
  • Colgate-Palmolive (Brunei) Sdn Bhn Brunei9
  • Colgate-Palmolive (Central America) Inc. Delaware9
  • Colgate-Palmolive (Central America) Inc. y Compañia Limitada Guatemala9
  • Colgate-Palmolive (Centro America) S.A. Guatemala9
  • Colgate-Palmolive (China) Co. Ltd China9
  • Colgate-Palmolive (Costa Rica), S.A. Costa Rica9
  • Colgate-Palmolive (Dominica), Inc. Delaware9
  • Colgate-Palmolive (Dominican Republic) Inc. Delaware9
  • Colgate-Palmolive (East Africa) Limited Kenya9
  • Colgate-Palmolive (Eastern) Pte. Ltd. Singapore9
  • Colgate-Palmolive (Fiji) Pte Limited Fiji9
  • Colgate-Palmolive (Gabon), S.A. Gabon9
  • Colgate-Palmolive (Gulf States) Ltd. United Arab Emirates9
  • Colgate-Palmolive (Guyana) Ltd. Guyana9
  • Colgate-Palmolive (H.K.) Limited Hong Kong9
  • Colgate-Palmolive (Hellas) S.A.I.C. Greece9
  • Colgate-Palmolive (India) Limited India9
  • Colgate-Palmolive (Kazakhstan), L.L.P. Kazakhstan9
  • Colgate-Palmolive (Latvia) Ltd. Latvia9
  • Colgate-Palmolive (Malaysia) Sdn Bhd Malaysia9
  • Colgate-Palmolive (Middle East Exports) Ltd. British Virgin Islands9
  • Colgate-Palmolive (Myanmar) Limited Myanmar9
  • Colgate-Palmolive (New York), Inc. Delaware9
  • Colgate-Palmolive (Poland) Sp. z o.o. Poland9
  • Colgate-Palmolive (Proprietary) Limited South Africa9
  • Colgate-Palmolive (Research & Development) Inc. Delaware9
  • Colgate-Palmolive (Romania) SRL Romania9
  • Colgate-Palmolive (Thailand) Limited Thailand9
  • Colgate-Palmolive (UK) Limited United Kingdom9
  • Colgate-Palmolive (Uganda) Limited Uganda9
  • Colgate-Palmolive (Vietnam) Ltd. Vietnam9
  • Colgate-Palmolive (Zambia) Inc. Delaware9
  • Colgate-Palmolive (Zimbabwe) Inc. Delaware9
  • Colgate-Palmolive A.B. Sweden9
  • Colgate-Palmolive A/S Denmark9
  • Colgate-Palmolive ACI Bangladesh Pvt. Limited Bangladesh9
  • Colgate-Palmolive Adria Ltd. Slovenia9
  • Colgate-Palmolive Arabia Ltd. Saudi Arabia9
  • Colgate-Palmolive Argentina S.A. Argentina9
  • Colgate-Palmolive Asia Pacific Limited Hong Kong9
  • Colgate-Palmolive Asia Pacific Treasury Services Limited Hong Kong9
  • Colgate-Palmolive Belgium S.A. Belgium9
  • Colgate-Palmolive Bolivia, Ltda. Bolivia9
  • Colgate-Palmolive Cameroun S.A. Cameroon9
  • Colgate-Palmolive Canada, Inc. Canada9
  • Colgate-Palmolive Caribbean Business LLC Puerto Rico9
  • Colgate-Palmolive Caricom Service Co., Inc. Puerto Rico9
  • Colgate-Palmolive Central European Management Inc. Delaware9
  • Colgate-Palmolive Chile S.A. Chile9
  • Colgate-Palmolive Cia. Delaware9
  • Colgate-Palmolive Comercial Ltda. Brazil9
  • Colgate-Palmolive Commercial (Hellas) SP LLC Greece9
  • Colgate-Palmolive Commericale S.r.l. Italy9
  • Colgate-Palmolive Compania Anonima Venezuela9
  • Colgate-Palmolive Company, Distr. LLC Puerto Rico9
  • Colgate-Palmolive Development Corp. Delaware9
  • Colgate-Palmolive East West Africa Region (Pty) Ltd South Africa9
  • Colgate-Palmolive Enterprises, Inc. Delaware9
  • Colgate-Palmolive Espana, S.A. Spain9
  • Colgate-Palmolive Europe Sarl Switzerland9
  • Colgate-Palmolive Global Trading Company Delaware9
  • Colgate-Palmolive Holding Argentina S.A. Argentina9
  • Colgate-Palmolive Hungary Kft, Limited Liability Company Hungary9
  • Colgate-Palmolive IHQ Services (Thailand) Limited Thailand9
  • Colgate-Palmolive Inc. Delaware9
  • Colgate-Palmolive Inc. S.A. Uruguay9
  • Colgate-Palmolive Industrial Ltda. Brazil9
  • Colgate-Palmolive Industriel S.A.S. France9
  • Colgate-Palmolive International Holding LLC Delaware9
  • Colgate-Palmolive International LLC Delaware9
  • Colgate-Palmolive Investment Co., Inc. Delaware9
  • Colgate-Palmolive Investments (BVI) Ltd. British Virgin Islands9
  • Colgate-Palmolive Investments (PNG) Ltd. Papua New Guinea9
  • Colgate-Palmolive Investments, (UK) Limited United Kingdom9
  • Colgate-Palmolive Investments, Inc. Delaware9
  • Colgate-Palmolive Israel Ltd. Israel9
  • Colgate-Palmolive Italia, S.r.l. Italy9
  • Colgate-Palmolive JSC Russia9
  • Colgate-Palmolive Lanka (Private) Limited Sri Lanka9
  • Colgate-Palmolive Latin America Inc. Delaware9
  • Colgate-Palmolive Limited New Zealand9
  • Colgate-Palmolive Manufacturing (Poland) Sp. z o.o. Poland9
  • Colgate-Palmolive Marketing Sdn Bhd Malaysia9
  • Colgate-Palmolive Maroc, S.A. Morocco9
  • Colgate-Palmolive Mocambique Limitada Mozambique9
  • Colgate-Palmolive Nederland B.V. Netherlands9
  • Colgate-Palmolive Norge A/S Norway9
  • Colgate-Palmolive Peru S.A. Peru9
  • Colgate-Palmolive Philippines, Inc. Philippines9
  • Colgate-Palmolive Pty Ltd Australia9
  • Colgate-Palmolive Retirement Trustee Limited New Zealand9
  • Colgate-Palmolive S.A.S. France9
  • Colgate-Palmolive S.r.l. Italy9
  • Colgate-Palmolive Services (Hellas) LLC Greece9
  • Colgate-Palmolive Services (Poland) Sp. z o.o. Poland9
  • Colgate-Palmolive Services CEW GmbH Germany9
  • Colgate-Palmolive Services, S.A. France9
  • Colgate-Palmolive Slovensko, s.r.o. Slovakia9
  • Colgate-Palmolive Support Services Unlimited Company Ireland9
  • Colgate-Palmolive Temizlik Urunleri Sanayi ve Ticart S.A. Turkey9
  • Colgate-Palmolive Transnational Inc. Delaware9
  • Colgate-Palmolive UK Group Limited United Kingdom9
  • Colgate-Palmolive Ukraine LLC Ukraine9
  • Colgate-Palmolive de Paraguay Sociedad Anonima Paraguay9
  • Colgate-Palmolive de Puerto Rico, Inc. Delaware9
  • Colgate-Palmolive del Ecuador, S.A.I.C. Ecuador9
  • Colgate-Palmolive del Peru (Delaware) Inc. Delaware9
  • Colgate-Palmolive Česká republika spol. s r.o. Czech Republic9
  • Colgate-Palmolive, Lda Portugal9
  • Colgate-Palmolive, S.A. de C.V. Mexico9
  • Colpal CBS, S de R. L. de C. V. Mexico9
  • Consumer Viewpoint Center, Inc. New Jersey9
  • Cotelle S.A. France9
  • Dimac Development Corp. Delaware9
  • EKIB, Inc. Delaware9
  • ELM Company Limited Bermuda9
  • Elta MD (Shanghai) Trade Co., Ltd. China9
  • Elta MD Holdings, Inc. Delaware9
  • FPN Pet Nutrition Pty Limited Australia9
  • FZG Holdings Limited Hong Kong9
  • Filorga Benelux SA Belgium9
  • Filorga Mexico Cosmetic, S.A. de C.V. Mexico9
  • Filorga Portugal, Unipessoal, Lda. Portugal9
  • Filorga RU, Limited Liability Company Russia9
  • GABA Europe Holding GmbH Switzerland9
  • GABA International Holding LLC Delaware9
  • GABA Schweiz AG Switzerland9
  • GABA Therwil GmbH Switzerland9
  • Gamma Development Co., Ltd. Thailand9
  • Global Trading and Supply LLC Delaware9
  • HPN Manufacturing Holdings, Inc. Delaware9
  • HPN Manufacturing, LLC Delaware9
  • Hamol Ltd. Delaware9
  • Hawley & Hazel (BVI) Company Ltd. British Virgin Islands9
  • Hill's Pet Nutrition (OAC) Limited United Kingdom9
  • Hill’s Funding Company Delaware9
  • Hill’s Pet Nutrition (NZ) Limited New Zealand9
  • Hill’s Pet Nutrition (Thailand) Co., Ltd. Thailand9
  • Hill’s Pet Nutrition Asia Limited Hong Kong9
  • Hill’s Pet Nutrition B.V. Netherlands9
  • Hill’s Pet Nutrition Canada Inc. Canada9
  • Hill’s Pet Nutrition Denmark ApS Denmark9
  • Hill’s Pet Nutrition Espana, S.L. Spain9
  • Hill’s Pet Nutrition GmbH Germany9
  • Hill’s Pet Nutrition Holding B.V. Netherlands9
  • Hill’s Pet Nutrition Indiana, Inc. Delaware9
  • Hill’s Pet Nutrition Italia, S.r.l. Italy9
  • Hill’s Pet Nutrition Ltd. United Kingdom9
  • Hill’s Pet Nutrition Manufacturing srl Italy9
  • Hill’s Pet Nutrition Manufacturing, B.V. Netherlands9
  • Hill’s Pet Nutrition Manufacturing, s.r.o Czech Republic9
  • Hill’s Pet Nutrition Norway AS Norway9
  • Hill’s Pet Nutrition OOO Russia9
  • Hill’s Pet Nutrition Pty. Limited Australia9
  • Hill’s Pet Nutrition SNC France9
  • Hill’s Pet Nutrition Sales, Inc. Delaware9
  • Hill’s Pet Nutrition South Africa Proprietary Limited South Africa9
  • Hill’s Pet Nutrition Sweden AB Sweden9
  • Hill’s Pet Nutrition Switzerland GmbH Switzerland9
  • Hill’s Pet Nutrition Taiwan, Ltd Taiwan9
  • Hill’s Pet Nutrition Trading (GZ) Co., Ltd China9
  • Hill’s Pet Nutrition de Mexico, S.A. de C.V. Mexico9
  • Hill’s Pet Nutrition s.r.o. Czech Republic9
  • Hill’s Pet Products (Benelux) S.A. Belgium9
  • Hill’s Pet Products, Inc. Delaware9
  • Hill’s Veterinary Companies of America, Inc. Delaware9
  • Hill’s-Colgate (Japan) Ltd. Japan9
  • Hygiene Systemes et Services SA Tunisia9
  • IES Enterprises, Inc. Massachusetts9
  • Inmobiliaria Colpal, S. de R.L. de C.V. Mexico9
  • Inmobiliaria Hills, S.A. de C.V. Mexico9
  • Innovacion Creativa, S.A. de C.V. Mexico9
  • Kolynos Corporation Delaware9
  • Laboratoires Filorga Cosmetiques Espana S.L.U. Spain9
  • Laboratoires Filorga Cosmetiques Italia S.R.L. Italy9
  • Laboratoires Filorga Cosmétiques S.A. France9
  • Lournay Sales, Inc. Delaware9
  • Mennen Interamerica, Ltd. Delaware9
  • Mennen Limited Delaware9
  • Mennen South Africa, Ltd. Delaware9
  • Mennen de Chile, Ltd. Delaware9
  • Mennen de Nicargua, S.A. Delaware9
  • Mission Hills Property Corporation Delaware9
  • Mission Hills, S.A. de C.V. Mexico9
  • Norwood International, Incorporated Delaware9
  • Olive Music Publishing Corporation Delaware9
  • P.T. Colgate Palmolive Indonesia Indonesia9
  • Paramount Research Inc. New York9
  • Penny, LLC Delaware9
  • Pet Chemicals, Inc. Florida9
  • Prime100 Pty Ltd Australia9
  • Prime100, LLC Delaware9
  • Productos Halogenados Copalven, C.A. Venezuela9
  • Purity Holding Company Delaware9
  • Purity Music Publishing Corporation Delaware9
  • Samuel Taylor Holdings B.V. Netherlands9
  • Sanxiao Company Limited Hong Kong9
  • Services Development Co., Ltd. Thailand9
  • Societe Generale de Negoce et de Services (GENESE) S.A. Tunisia9
  • The GDN - The Global Distributive Network SAS France9
  • The Lournay Company, Inc. Delaware9
  • The MPDP - The Medical and Pharmaceutic Distributive Platform SAS France9
  • The Murphy-Phoenix Company Ohio9
  • Tom’s of Maine Holdings, Inc. Delaware9
  • Tom’s of Maine, Inc. Maine9
  • Vipont Pharmaceutical, Inc. Delaware9

From Wikidata.1 The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Acquisitions

  1. 2004Acquired Elmex1

Former names

  • COLGATE PALMOLIVE COMay 18, 1994 to Oct 2, 20267

Timeline

  1. Jul 31, 20268-K Results of operations127
  2. May 13, 20268-K Shareholder vote128
  3. May 1, 20268-K Results of operations; Exit or restructuring costs129
  4. Apr 9, 20268-K Executive or director change130
  5. Mar 17, 20268-K Other events131
  6. Mar 12, 20268-K Executive or director change132
  7. Jan 30, 20268-K Results of operations133
  8. Nov 10, 20258-K Other events134
  9. Oct 31, 20258-K Results of operations; Exit or restructuring costs135
  10. Aug 1, 20258-K Results of operations; Exit or restructuring costs136
  11. May 29, 20258-K Executive or director change137
  12. May 14, 20258-K Shareholder vote138
  13. 2019New chief executive Noel Wallace becomes CEO1
  14. May 20, 2013New chief executive Peter Brons-Poulsen becomes CEO24
  15. May 15, 2009New chief executive Neil Thompson becomes CEO25
  16. Aug 10, 2007New chief executive Ian M. Cook becomes CEO26
  17. Nov 5, 2003New chief executive Reuben Mark becomes CEO28
  18. Aug 12, 2003New chief executive Robert C. Wheeler becomes CEO27
  19. Jan 2, 1990Went public Listed on NYSE1
  20. 1806Founded Founded1

Calendar

Coming up

  1. Oct 30, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported $0.91 a share, on Oct 31, 2025.139

When it reported results

  1. Jul 31, 2026Reported quarterly or annual results127
  2. May 1, 2026Reported quarterly or annual results129
  3. Jan 30, 2026Reported quarterly or annual results133
  4. Oct 31, 2025Reported quarterly or annual results135
  5. Aug 1, 2025Reported quarterly or annual results136
  6. Apr 25, 2025Reported quarterly or annual results140
  7. Jan 31, 2025Reported quarterly or annual results141
  8. Jan 24, 2025Reported quarterly or annual results142

Drug trials and FDA: coming up

  1. Oct 2026Phase 3 trial readout expected Phase 3 trial of Fluoride toothpaste containing 750 ppm MFP in a Dical base, Fluoride toothpaste containing 1450 ppm MFP in a Dical base and others in Remineralization: primary completion expected Oct 2026 (ClinicalTrials.gov NCT07625670).143
  2. Nov 2026Phase 3 trial readout expected Phase 3 trial of Colgate SNaP Total 10/10, 1.5 Taurate and Colgate Great Regular Flavor Toothpaste in Plaque, Dental: primary completion expected Nov 2026 (ClinicalTrials.gov NCT07605338).144
  3. Dec 15, 2026Phase 4 trial readout expected Phase 4 trial of 0.09% CPC + Zinc Lactate Mouthwash and 0.2% Chlorhexidine Mouthwash in Bacterial Contamination: primary completion expected Dec 15, 2026 (ClinicalTrials.gov NCT07880509).145
  4. Dec 20, 2026Phase 4 trial readout expected Phase 4 trial of Prevident 5000ppm Booster Plus Toothpaste in Enamel Lesions: primary completion expected Dec 20, 2026 (ClinicalTrials.gov NCT07819370).146
  5. Jan 2027Phase 3 trial readout expected Phase 3 trial of 0.45% SnF HW with NaF (1450 F), 67% Bicarbonate with NaF (1400 F) and others in Plaque: primary completion expected Jan 2027 (ClinicalTrials.gov NCT07842991).147
  6. Apr 2027Phase 3 trial readout expected Phase 3 trial of Silica Free Meridol, Meridol and others in Gingivitis: primary completion expected Apr 2027 (ClinicalTrials.gov NCT07842978).148

Drug trials and FDA: recently

  1. Jul 5, 2026Phase 3 trial completed Phase 3 trial of Max Fresh Toothpaste and Colgate Cavity Protection Toothpaste in Oral Malodor: primary completion Jul 5, 2026, no results posted yet (ClinicalTrials.gov NCT07398378).149
  2. Jun 28, 2026Phase 3 trial completed Phase 3 trial of stannous fluoride toothpaste and 0.76% Sodium Monofluorophosphate (Na MFP) toothpaste in Plaque: primary completion Jun 28, 2026, no results posted yet (ClinicalTrials.gov NCT07458464).150
  3. Jun 6, 2026Phase 3 trial completed Phase 3 trial of Colgate 360 SupraClean Manual Toothbrush brush with 0.76% Na MFP, (1000 ppm F) and Colgate Adult Extra Clean soft-bristle toothbrush brush with 0.76% Na MFP, (1000 ppm F) in Bacterial Load Reduction: primary completion Jun 6, 2026, no results posted yet (ClinicalTrials.gov NCT07471477).151

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Filings

529 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 45 major events, 341 insider forms, 14 large holders, 109 other. The latest 20:

  1. Oct 2, 20264 EDGAR
  2. Oct 2, 20264 EDGAR
  3. Oct 2, 20264 EDGAR
  4. Sep 18, 20264 EDGAR
  5. Sep 18, 20264 EDGAR
  6. Sep 18, 20264 EDGAR
  7. Sep 18, 20264 EDGAR
  8. Sep 18, 20264 EDGAR
  9. Sep 18, 20264 EDGAR
  10. Sep 18, 20264 EDGAR
  11. Sep 18, 20264 EDGAR
  12. Sep 15, 20264 EDGAR
  13. Sep 15, 20264 EDGAR
  14. Sep 15, 20264 EDGAR
  15. Sep 15, 20264 EDGAR
  16. Sep 15, 20264 EDGAR
  17. Sep 15, 20264 EDGAR
  18. Sep 15, 20264 EDGAR
  19. Sep 15, 20264 EDGAR
  20. Aug 26, 20264 EDGAR

The 529 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

102 open-market trades by officers, directors and large owners since October 2021: 0 buys and 102 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 24, 2026Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinSale10,000$92.05$920.5KForm 4
Aug 6, 2026CAHILL JOHN TDirectorSale4,170$93.37$389.4KForm 4
Aug 5, 2026Wallace Noel R.Chairman, President & CEOSale161,021$92.52$14.9MForm 4
Aug 4, 2026Wallace Noel R.Chairman, President & CEOSale161,021$91.92$14.8MForm 4
May 15, 2026Malcolm GregoryEVP and ControllerSale2,300$88.44$203.4KForm 4
May 7, 2026Massey SallyChief People OfficerSale8,599$87.41$751.6KForm 4
Feb 12, 2026Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinSale15,000$97.81$1.5MForm 4
Feb 11, 2026Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinSale35,000$94.61$3.3MForm 4
Feb 10, 2026Hazlin JohnChief Growth OfficerSale20,989$94.25$2.0MForm 4
Feb 6, 2026Malcolm GregoryEVP and ControllerSale12,747$94.91$1.2MForm 4
Feb 5, 2026Massey SallyChief People OfficerSale15,851$95.03$1.5MForm 4
Feb 4, 2026SUTULA STANLEY J IIIChief Financial OfficerSale97,843$94.27$9.2MForm 4
Feb 4, 2026Daniels JenniferCLO and SecretarySale22,000$94.34$2.1MForm 4
Feb 4, 2026Wallace Noel R.Chairman, President & CEOSale45,568$93.91$4.3MForm 4
Nov 21, 2025Massey SallyChief People OfficerSale1,237$80.89$100.1KForm 4
May 15, 2025Massey SallyChief People OfficerSale2,250$88.97$200.2KForm 4
Feb 25, 2025Massey SallyChief People OfficerSale8,000$92.02$736.2KForm 4
Nov 26, 2024Malcolm GregoryEVP and ControllerSale1,054$95.94$101.1KForm 4
Nov 22, 2024Wallace Noel R.Chairman, President & CEOSale33,333$95.00$3.2MForm 4
Nov 5, 2024SUTULA STANLEY J IIIChief Financial OfficerSale45,410$94.11$4.3MForm 4

All 102 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Noel WallaceChairman, President and Chief Executive Officer$1.5M$16.5M156
2025Shane GrantChief Operating Officer, Americas$592.3K$11.9M156
2025Stanley J. Sutula IIIChief Financial Officer$1.1M$5.7M156
2025Panagiotis TsourapasChief Operating Officer, Eur., APac, Afr/Eur, Skin and Global Cust. Dev.$1.0M$4.1M156
2025Jennifer M. DanielsChief Legal Officer and Secretary$952.7K$3.8M156
2024Noel WallaceChairman, President and Chief Executive Officer$1.5M$18.2M156
2024Stanley J. Sutula IIIChief Financial Officer$1.0M$5.9M156
2024Panagiotis TsourapasChief Operating Officer, Eur., APac, Afr/Eur, Skin and Global Cust. Dev.$947.2K$4.5M156
2024Jennifer M. DanielsChief Legal Officer and Secretary$921.8K$4.4M156
2023Noel WallaceChairman, President and Chief Executive Officer$1.5M$17.1M156
2023Stanley J. Sutula IIIChief Financial Officer$959.8K$5.7M156
2023Panagiotis TsourapasChief Operating Officer, Eur., APac, Afr/Eur, Skin and Global Cust. Dev.$908.5K$4.4M156
2023Jennifer M. DanielsChief Legal Officer and Secretary$880.1K$4.2M156

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.69,915,472$6.4B0.1%−2,727,530
Vanguard Capital Management LLC52,246,333$4.8B0.1%+26,509
State Street Corp47,020,966$4.3B0.1%−698,516
Vanguard Portfolio Management LLC24,021,137$2.2B0.1%+198,391
Geode Capital Management, LLC23,144,319$2.1B0.1%+244,029
Morgan Stanley22,072,925$2.0B0.1%+1,191,571
First Eagle Investment Management, LLC16,411,398$1.5B1.2%+8,294,616
Bank of New York Mellon Corp13,532,417$1.2B0.2%+1,010,872
Deutsche Bank Ag\11,751,973$1.1B0.3%−176,188
Norges Bank9,686,029$888.0M0.1%New
Fmr LLC8,983,071$823.6M0.0%−25,914
Goldman Sachs Group Inc8,571,015$785.8M0.1%−904,819
Northern Trust Corp8,471,575$776.7M0.1%−209,188
Invesco Ltd.8,325,612$763.3M0.1%−13,381
State Farm Mutual Automobile Insurance Co6,730,570$617.1M0.4%No change
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC6,471,404$593.3M0.1%−357,560
Amundi6,218,257$570.1M0.1%+1,033,918
Bank Of America Corp /de/6,189,824$567.5M0.0%−447,773
Royal Bank Of Canada5,591,400$512.6M0.1%+651,387
Legal & General Group Plc5,416,333$496.6M0.1%−300,641
Dimensional Fund Advisors LP5,328,913$488.6M0.1%+138,875
Ameriprise Financial Inc5,226,139$479.1M0.1%+25,818
Charles Schwab Investment Management Inc5,148,163$472.0M0.1%+26,861
Wellington Management Group Llp5,111,313$468.6M0.1%−246,439
Franklin Resources Inc5,108,786$468.4M0.1%−770,945

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

34 trades disclosed by members of Congress, the latest 25. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Sep 2, 2026Kevin HernRepublican, HousePartial sale$1,001 - $15,000−3.6%Report
Aug 31, 2026Kevin HernRepublican, HouseSale$1,001 - $15,000−4.2%Report
Aug 27, 2026Kevin HernRepublican, HousePartial sale$1,001 - $15,000−3.4%Report
Aug 19, 2026Kevin HernRepublican, HouseSale$1,001 - $15,000−3.2%Report
Oct 6, 2025Rick LarsenDemocratic, HouseSale$1,001 - $15,000−6.6%Report
Sep 25, 2025Julie JohnsonDemocratic, HouseSale$1,001 - $15,000−0.8%Report
Sep 23, 2025Julie JohnsonDemocratic, HouseBuy$1,001 - $15,000+1.0%Report
Sep 23, 2025Julie JohnsonDemocratic, HouseSale$1,001 - $15,000−1.0%Report
Sep 11, 2025Lisa C. McClainRepublican, HouseSale$1,001 - $15,000+5.4%Report
Sep 10, 2025Tim MooreRepublican, HouseSale$1,001 - $15,000+5.2%Report
Aug 13, 2025Lisa C. McClainRepublican, HouseBuy$1,001 - $15,000−10.7%Report
Jul 31, 2025Shelley Moore CapitoRepublican, SenateSale$1,001 - $15,000+9.9%Report
Jul 11, 2025Ritchie TorresDemocratic, HouseSale$1,001 - $15,000+18.7%Report
Jun 24, 2025Lisa C. McClainRepublican, HouseSale$1,001 - $15,000+20.5%Report
Jun 17, 2025Lisa C. McClainRepublican, HouseBuy$1,001 - $15,000−23.0%Report
Jan 9, 2024Rick LarsenDemocratic, HouseBuy$1,001 - $15,000−46.4%Report
Aug 25, 2023Jeff Duncan, HouseSale$1,001 - $15,000+48.0%Report
Sep 7, 2022Lois FrankelDemocratic, HousePartial sale$1,001 - $15,000+74.2%Report
Aug 10, 2022Lois FrankelDemocratic, HousePartial sale$1,001 - $15,000+66.6%Report
Jul 21, 2022Lois FrankelDemocratic, HousePartial sale$1,001 - $15,000+70.0%Report
Apr 7, 2021Lois FrankelDemocratic, HouseBuy$1,001 - $15,000−71.6%Report
Mar 29, 2021Tommy TubervilleRepublican, SenateSale$1,001 - $15,000+77.2%Report
Feb 10, 2021Lois FrankelDemocratic, HouseBuy$1,001 - $15,000−78.9%Report
Jan 28, 2021Lois FrankelDemocratic, HouseBuy$1,001 - $15,000−85.5%Report
Apr 29, 2020Gilbert Ray Cisneros, Jr.Democratic, HouseBuy$1,001 - $15,000−129.1%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Colgate-Palmolive Company is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCOLGATE PALMOLIVE CO2
  • CIK0000021665
  • Employer ID (EIN)13-181559522
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company22
  • Incorporated inDelaware22
  • Fiscal year endsDecember 312
  • Industry code (SIC)2844 Perfumes, Cosmetics & Other Toilet Preparations2
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance2
  • Business address300 Park Ave, New York, NY 100222
  • Phone21231020002
  • Shares outstanding797,172,829 as of Jun 30, 202617
  • Public float$73.4B as of Jun 30, 202522
  • AuditorPricewaterhouseCoopers LLP, New York, New York PCAOB ID 238; it also attests to the company’s internal control over financial reporting22
  • On EDGAR sinceFeb 14, 19942
  • Filings3,949 in all: 4 (2,918), 8-K (222), 10-Q (98), 3 (59), 424B3 (58), 5 (56), 424B2 (54), 144 (51)2
    All 45 form types

    SC 13G/A (50), DEFA14A (48), 11-K (41), DEF 14A (33), FWP (33), 10-K (29), UPLOAD (29), SC 13G (25), CORRESP (23), ARS (16), 4/A (13), S-8 (13), SD (13), 8-A12B (7), S-3ASR (6), 424B5 (5), NO ACT (5), S-3 (5), 10-K405 (4), 25-NSE (4), 8-K/A (4), CERT (4), 3/A (3), PRE 14A (3), CERTNYS (2), S-3/A (2), S-8 POS (2), SCHEDULE 13G/A (2), 10-K/A (1), 10-Q/A (1), 15-12B (1), 25 (1), 5/A (1), DEFR14A (1), PRER14A (1), PX14A6G (1), SCHEDULE 13G (1)

  • Latest filingsAnnual report (10-K) Feb 23, 2026
    Quarterly report (10-Q) Jul 31, 2026
    Proxy statement (DEF 14A) Mar 25, 2026
    Latest 8-K (8-K) Jul 31, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, $1.00 par valueCLNew York Stock Exchange
0.500% Notes due 2026CL26New York Stock Exchange
0.300% Notes due 2029CL29New York Stock Exchange
1.375% Notes due 2034CL34New York Stock Exchange
3.250% Notes due 2035CL35New York Stock Exchange
0.875% Notes due 2039CL39New York Stock Exchange

From the cover page of the 10-K filed Feb 23, 2026 (Section 12(b) of the Exchange Act).22

Risk factors and legal proceedings

The risks Colgate-Palmolive Company names in Item 1A of its 10-K filed Feb 23, 2026: 18 risks under these headings, as written.22

  • Business and Industry Risks
  • We face risks associated with significant international operations, including exposure to foreign currency fluctuations.
  • Significant competition in our industry could adversely affect our business.
  • The rapidly changing retail landscape and changing consumer preferences may adversely affect our business.
  • The growth of our business depends on the successful identification, development and launch of innovative new products.
  • Damage to our reputation could have an adverse effect on our business.
  • Our success depends upon our ability to recruit, attract and retain key employees and the succession of senior management.
  • We have pursued and may continue to pursue acquisitions and divestitures, which could adversely impact our business.
  • Operational Risks
  • Our business results are impacted by our ability to manage disruptions in our global supply chain and/or key office facilities.
  • Volatility in material and other costs has in the past and may continue to adversely impact our profitability.
  • There is no guarantee that our ongoing efforts to reduce costs will be successful.
The other 8 risks
  • We may not realize the benefits that we expect from our Strategic Growth and Productivity Program.
  • A cybersecurity incident, data incident or a failure of key technology systems could adversely impact our business.
  • Climate change and other sustainability matters could have an adverse impact on our business and results of operations.
  • Our reliance on third parties in many aspects of our business could have an adverse effect on our business and results of operations.
  • Legal and Regulatory Risks
  • Legal claims and proceedings could adversely impact our business.
  • Financial and Economic Risks
  • Uncertain or unfavorable global macroeconomic and geopolitical conditions may adversely affect our business.
  • Disruptions in the credit markets or changes to our credit ratings may adversely affect our business.
  • Tax matters, including changes in tax rates, disagreements with taxing authorities and imposition of new taxes could negatively impact our business.

Legal proceedings

For information regarding legal proceedings, refer to Note 13, Commitments and Contingencies to the Consolidated Financial Statements included in Part IV, Item 15 of this report.

The opening of Item 3, Legal Proceedings.22

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Yahoo FinanceCL quote
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99
  100. 100
  101. 101
  102. 102
  103. 103
  104. 104
  105. 105
  106. 106
  107. 107
  108. 108
  109. 109
  110. 110
  111. 111
  112. 112
  113. 113
  114. 114
  115. 115
  116. 116
  117. 117
  118. 118
  119. 119
  120. 120
  121. 121
  122. 122
  123. 123
  124. 124
  125. 125
  126. 126
  127. 127
  128. 128
  129. 129
  130. 130
  131. 131
    SEC EDGAROther events
  132. 132
  133. 133
  134. 134
    SEC EDGAROther events
  135. 135
  136. 136
  137. 137
  138. 138
  139. 139
  140. 140
  141. 141
  142. 142
  143. 143
  144. 144
  145. 145
  146. 146
  147. 147
  148. 148
  149. 149
  150. 150
  151. 151
  152. 152
  153. 153
  154. 154
  155. 155
  156. 156